MARKET

LNTH

LNTH

Lantheus Hldg
NASDAQ

Real-time Quotes | Nasdaq Last Sale

18.68
-0.47
-2.45%
After Hours: 18.68 0 0.00% 16:14 02/26 EST
OPEN
18.02
PREV CLOSE
19.15
HIGH
19.15
LOW
17.27
VOLUME
762.49K
TURNOVER
--
52 WEEK HIGH
20.29
52 WEEK LOW
8.67
MARKET CAP
1.25B
P/E (TTM)
217.72
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
--Analyst Actions: Credit Suisse Raises Lantheus Holdings' Price Target to $17 from $14 After Q4 2020 Results Exceed Estimates, Keeps Neutral Rating
MT Newswires · 11h ago
10-K: LANTHEUS HOLDINGS, INC.
(EDGAR Online via COMTEX) -- Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations The following discussion and...
Edgar Online - (EDG = 10Q, 10K) · 1d ago
Recap: Lantheus Holdings Q4 Earnings
Shares of Lantheus Holdings (NASDAQ:LNTH) fell in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were down 79.41% year over year to $0.07, which beat the estimate of $0.01. Revenue of $94,152,000 up by 5.38...
Benzinga · 1d ago
Lantheus Holdings Q4 EPS $0.07 Beats $0.01 Estimate, Sales $94.15M Beat $92.23M Estimate
Lantheus Holdings (NASDAQ:LNTH) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.01 by 600 percent. This is a 79.41 percent decrease over earnings of $0.34 per share from the
Benzinga · 1d ago
Lantheus EPS beats by $0.06, beats on revenue
Lantheus (LNTH): Q4 Non-GAAP EPS of $0.07 beats by $0.06; GAAP EPS of -$0.05.Revenue of $94.2M (+5.4% Y/Y) beats by $2.79M.Press Release
Seekingalpha · 1d ago
Lantheus Holdings Sees FY21 Adj EPS 34c-Adj EPS 39c >LNTH
Lantheus Holdings Sees FY21 Adj EPS 34c-Adj EPS 39c >LNTH
Dow Jones · 1d ago
Lantheus Holdings Sees 1Q Adj Loss/Shr 3c-Adj EPS 0c >LNTH
Lantheus Holdings Sees 1Q Adj Loss/Shr 3c-Adj EPS 0c >LNTH
Dow Jones · 1d ago
Lantheus Holdings Sees FY21 Rev $385M-$400M >LNTH
Lantheus Holdings Sees FY21 Rev $385M-$400M >LNTH
Dow Jones · 1d ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of LNTH. Analyze the recent business situations of Lantheus Hldg through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average LNTH stock price target is 19.80 with a high estimate of 24.00 and a low estimate of 14.00.
EPS
Institutional Holdings
Institutions: 354
Institutional Holdings: 64.98M
% Owned: 97.17%
Shares Outstanding: 66.87M
TypeInstitutionsShares
Increased
45
5.35M
New
59
-742.14K
Decreased
58
4.22M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.61%
Healthcare Equipment & Supplies
-0.63%
Key Executives
Non-Executive Chairman/Independent Director
Brian Markison
President/Chief Executive Officer/Director
Mary Heino
Chief Financial Officer/Treasurer
Robert Marshall
Chief Operating Officer/Senior Vice President
John Bolla
Senior Vice President/General Counsel
Michael Duffy
Senior Vice President
Etienne Montagut
Senior Vice President
Simon Robinson
Senior Vice President
Carol Walker
Other
Paul Blanchfield
Other
Istvan Molnar
Independent Director
Gerard Ber
Independent Director
James Clemmer
Independent Director
Samuel Leno
Independent Director
Heinz Mausli
Independent Director
Heinz Maeusli
Independent Director
Julie McHugh
Independent Director
Gary Pruden
Independent Director
Frederick Robertson
Independent Director
James Thrall
  • Dividends
  • Splits
  • Insider Activity
No Data
About LNTH
Lantheus Holdings, Inc. is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging. It operates in two segments: U.S. Segment and International Segment. The U.S. Segment produces and markets its medical imaging agents and products throughout the United States. In the United States, it sells its products to radiopharmacies, integrated delivery networks, hospitals, clinics and group practices. The International Segment operations consist of production and distribution activities in Puerto Rico and direct distribution activities in Canada. Its portfolio of nine commercial products is diversified across a range of imaging modalities. Its products include an ultrasound contrast agent and medical radiopharmaceuticals.

Webull offers kinds of Lantheus Holdings Inc stock information, including NASDAQ:LNTH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LNTH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LNTH stock methods without spending real money on the virtual paper trading platform.